申请人:Takeda Pharmaceutical Company Limited
公开号:EP2385032A1
公开(公告)日:2011-11-09
The GPR40 receptor function regulator of the present invention, which comprises a compound having an aromatic ring and a group capable of releasing cation is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
本发明的 GPR40 受体功能调节剂由具有芳香环和能够释放阳离子的基团的化合物组成,可用作胰岛素分泌剂或预防或治疗糖尿病等的药物。